Diabetes
Advertisement
Researchers, led by Yehuda Handelsman, conducted a post-hoc analysis of the ATHENA and EURIDIS/ADONIS studies and ...
According to Silvia Giovannini and colleagues from the Università Cattolica del Sacro Cuore in Rome, Italy, recent ...
Diabetes mellitus (DM) is a common comorbidity in patients with atrial fibrillation (AF) and is associated with an ...
A new high-sensitivity cardiac troponin helps predict adverse cardiovascular events in diabetic patients with critical ...
Patients with diabetes have a much higher risk of complications following coronary artery bypass surgery compared with ...
A recent study in Cardiovascular Diabetology suggests that diabetics with no obstructive coronary artery disease (CAD) ...
Empagliflozin was associated with reduced risk for cardiovascular death regardless of patient diabetes status, a newly ...
Dapagliflozin reduced cardiovascular morbidity and mortality in patients with heart failure with reduced ejection ...
Diabetes mellitus is an independent predictor for heart failure, according to the findings of a study published in Mayo ...
A new study found that the Eli Lilly and Boehringer Ingelheim (BI) drug empagliflozin (Jardiance), used to treat ...
A cross-sectional study has found that the correlation between dietary fatty acid and hypertension varies significantly ...
Albiglutide was superior to placebo for the reduction of major adverse cardiac events (MACE) in patients with type ...
The use of omega-3 (n-3) fatty acid supplements, often in the form of fish oil, was not associated with a reduction ...
Canagliflozin, a sodium glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular (CV) death ...
An analysis of a subset of patients from the CANTOS trial suggested that canakinumab does not prevent prediabetes from ...
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.